Previous 10 | Next 10 |
2023-11-28 05:48:31 ET Novartis ( NYSE: NVS ) has raised its mid-term sales growth target citing strong momentum of key growth drivers, majority of which are de-risked existing brands. Net sales is now expected to rise at a compound annual growth rate of 5% through 2027, compare...
2023-11-24 11:15:15 ET More on Novartis Novartis AG (NVS) 10th Annual ESG Investor Event Conference (Transcript) Sandoz Group: Novartis Spinoff With A Double-Digit EBITDA CAGR Through 2028 New And Improved Novartis Novartis licenses CAR-T candidate from Legen...
2023-11-19 09:56:29 ET Summary WisdomTree International Quality Dividend Growth Fund selects ex-North America dividend stocks with quality and expected earnings growth characteristics. The fund is well-diversified across countries, sectors, and holdings, with a focus on Europe. ...
2023-11-19 02:00:00 ET Summary Legend Biotech partners with Novartis in a $1.2 billion deal to develop and commercialize DLL3 CAR-T candidates. WuXi XDC, an ADC/bioconjugate CRDMO, raises $520 million in a successful IPO in Hong Kong. Shanghai SciClone Pharma acquires China ri...
2023-11-16 23:16:56 ET Summary Vertex Pharmaceuticals Incorporated is a global $90-billion market-cap biotechnology company specializing in developing transformative medicines. Despite the close-to-zero growth in EPS, the Company maintained a strong financial position, ending the ...
2023-11-14 14:27:51 ET More on UCB SA FDA approves UCB's Bimzelx for plaque psoriasis Historical earnings data for UCB SA Dividend scorecard for UCB SA Financial information for UCB SA For further details see: UCB launches newly approved psoriasis...
2023-11-14 08:45:50 ET Palm Beach, FL – November 14, 2023 – FinancialNewsMedia.com News Commentary – Oncology drugs include wide range of medications such as targeted therapies, chemotherapy agents, immunotherapies, and hormone therapies to treat cancer. The...
2023-11-13 15:34:43 ET More on etc. Hapag-Lloyd - Shipping In A Downcycle, I Say 'HOLD' For Now 3 Decades And Nothing To Show For It Novartis AG (NVS) 10th Annual ESG Investor Event Conference (Transcript) Moleculin Biotech gains after early data for lead can...
2023-11-13 15:24:10 ET Novartis AG (NVS) 10th Annual ESG Investor Event Conference November 13, 2023 10:30 AM ET Company Participants Maria Victoria Cuevas - IR Vas Narasimhan - CEO Lutz Hegemann - President, Global Health & Sustainability Thierry Diagana...
2023-11-13 11:23:34 ET More on Legend Biotech, Novartis, etc. Sandoz Group: Novartis Spinoff With A Double-Digit EBITDA CAGR Through 2028 New And Improved Novartis Novartis AG (NVS) Q3 2023 Earnings Call Transcript FDA approves Novartis drug Cosentyx for hidr...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...